Skip to main content

Table 1 Secondary objectives of the HYPER-LIV01 trial

From: Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases

Tolerance
Post-operative mortality
Post-operative morbidity
Post-hepatectomy liver failure
Rate of non-resectability due to insufficient FRL
Rate of non-resectability due to tumor progression
Per-operative difficulties (adhesions, pedicular dissection …)
Blood loss, operating time, transfusions
R0 resection rate
Post-operative liver volume
Overall survival
\